During the past decade, Geauga Hospital conducted 82 clinical trials. In the 10-year time frame, 82 clinical trials started and 36 clinical trials were completed, i.e. on average, 43.9% percent of trials that started reached the finish line to date. In the past 5 years, 28 clinical trials started and 32 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Geauga Hospital" #1 sponsor was "National Cancer Institute (NCI)" with 40 trials, followed by "SWOG Cancer Research Network" with 22 trials sponsored, "NRG Oncology" with 14 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 10 trials sponsored and "Alliance for Clinical Trials in Oncology" with 10 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 13 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Geauga Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 67 trials as a collaborator, "NRG Oncology" with 24 trials as a collaborator, "Canadian Cancer Trials Group" with 6 trials as a collaborator, "Radiation Therapy Oncology Group" with 3 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Geauga Hospital" are "Recurrent Squamous Cell Lung Carcinoma" (8 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (7 trials), "Invasive Breast Carcinoma" (6 trials), "Stage IV Lung Cancer AJCC v8" (6 trials) and "Breast Cancer" (5 trials). Many other conditions were trialed in "Geauga Hospital" in a lesser frequency.

Most popular intervention types in "Geauga Hospital" are "Drug" (87 trials), "Other" (65 trials), "Biological" (44 trials), "Radiation" (37 trials) and "Procedure" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (35 trials), "Quality-of-Life Assessment" (25 trials), "Cisplatin" (15 trials), "Computed Tomography" (15 trials) and "Questionnaire Administration" (15 trials). Other intervention names were less common.

The vast majority of trials in "Geauga Hospital" are 85 trials for "All" genders, 20 trials for "Female" genders and 9 trials for "Male" genders.

Currently, there are NaN active trials in "Geauga Hospital". 1 are not yet recruiting, 27 are recruiting, 59 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 20 completed trials in Geauga Hospital, 3 suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Geauga Hospital, 3 "Phase 1" clinical trials were conducted, 52 "Phase 2" clinical trials and 65 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 3 trials that are defined as “Not Applicable".